Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?

被引:0
作者
Steinberg-Vorhoff, Hannah L. [1 ]
Ting, Saskia C. [2 ]
Zensen, Sebastian [1 ]
Ludwig, Johannes M. [3 ]
Li, Yan [1 ]
Richly, Heike [4 ]
Grueneisen, Johannes [1 ]
Siveke, Jens T. [5 ,6 ,7 ]
Theysohn, Jens M. [1 ]
Schaarschmidt, Benedikt M. [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany
[2] Univ Hosp Essen, Inst Pathol, Essen, Germany
[3] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiol & Nucl Med, Mannheim, Germany
[4] Univ Duisburg Essen, Sarcoma Ctr, West German Canc Ctr, Dept Med Oncol, Essen, Germany
[5] Univ Hosp Essen, West German Canc Ctr, Inst Dev Canc Therapeut, Essen, Germany
[6] German Canc Consortium DKTK, Div Solid Tumor Translat Oncol, Partner Site Essen, Heidelberg, Germany
[7] German Canc Res Ctr, DKFZ, German, Heidelberg, Germany
关键词
HAIC; hepatic artery infusion therapy; histomorphological pattern; prognosis; survival; CALLENDER CLASSIFICATION; LIVER METASTASES; DISEASE; INTRAARTERIAL; FOTEMUSTINE; EXPERIENCE; PROGNOSIS; FAILURE; BENEFIT; TRENDS;
D O I
10.1111/1754-9485.13783
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction:<bold> </bold>In uveal melanoma (UM) patients with hepatic metastases, hepatic artery infusion chemotherapy (HAIC) is a viable, palliative treatment option. To evaluate the impact of two histomorphological patterns (spindle cell vs. epithelioid) of liver metastases on median overall survival (mOS) in UM patients undergoing HAIC. Methods:<bold> </bold>A retrospective analysis with 60 UM patients (29 females, mean age: 61.6 +/- 12.1 years) with hepatic metastases was performed. Histomorphological patterns in metastases were analysed and classified as either predominant spindle cell or epithelioid pattern. mOS between both patient groups was analysed using Kaplan-Meier curves and the log-rank test. Results:<bold> </bold>In 73.3% (44/60) of the metastases, a predominant epithelioid pattern, in 21.7% (13/60) a predominant spindle cell pattern, and in 5% (3/60) other patterns were found. No significant differences between patients with an epithelioid (mOS: 14.2 months, 95% CI: 8.8-19.6) and a spindle cell pattern (mOS: 14.4 months, 95% CI: 4.3-24.5) were detected by the log-rank test, chi(2)(2) = 0.22, P = 0.881. Conclusion:<bold> </bold>Histomorphological patterns of UM metastases do not seem to be a predictor for mOS in UM patients undergoing HAIC.
引用
收藏
页码:862 / 869
页数:8
相关论文
共 50 条
  • [21] Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer
    Endo, Shinya
    Kawaguchi, Shinya
    Terada, Shuzo
    Shirane, Naofumi
    INTERNAL MEDICINE, 2021, 60 (02) : 223 - 229
  • [22] Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma
    Koea, JB
    Kemeny, N
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 19 (02): : 125 - 134
  • [23] Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
    Tong, T. M. L.
    Samim, M.
    Kapiteijn, E.
    Meijer, T. S.
    Speetjens, F. M.
    Bruening, R.
    Schroeder, T. H.
    El-Sanosy, S.
    Maschke, H.
    Wacker, F. K.
    Vogel, A.
    Dewald, C. L. A.
    Goeman, J. J.
    Burgmans, M. C.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (09) : 1304 - 1313
  • [24] Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
    Sajan, Abin
    Fordyce, Samuel
    Sideris, Andrew
    Liou, Connie
    Toor, Zeeshan
    Filtes, John
    Krishnasamy, Venkatesh
    Ahmad, Noor
    Reis, Stephen
    Brejt, Sidney
    Baig, Asad
    Khan, Shaheer
    Caplan, Michael
    Sperling, David
    Weintraub, Joshua
    DIAGNOSTICS, 2023, 13 (11)
  • [25] Results of Hepatic Arterial Infusion Chemotherapy in Patients with Unresectable Liver Metastases
    Goi, Takanori
    Sawai, Katsuji
    Koneri, Kenji
    Katayama, Kanji
    Yamaguchi, Akio
    VISZERALMEDIZIN, 2011, 27 (05): : 397 - 401
  • [26] Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study
    Vogl, Thomas J.
    Koch, Silvia A.
    Lotz, Goesta
    Gebauer, Bernhard
    Willinek, Winfried
    Engelke, Christoph
    Bruening, Roland
    Zeile, Martin
    Wacker, Frank
    Vogel, Arndt
    Radeleff, Boris
    Scholtz, Jan-Erik
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (06) : 864 - 872
  • [27] Hepatic Artery Infusion Chemotherapy for Liver Malignancy
    Leal, Julie N.
    Kingham, T. Peter
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (01) : 121 - +
  • [28] Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma
    Mariani, Pascale
    Bidard, Francois-Clement
    Rampanou, Aurore
    Houy, Alexandre
    Servois, Vincent
    Ramtohul, Toulsie
    Pierron, Gaelle
    Chevrier, Marion
    Renouf, Benjamin
    Lantz, Olivier
    Gardrat, Sophie
    Vincent-Salomon, Anne
    Roman-Roman, Sergio
    Rodrigues, Manuel
    Piperno-Neumann, Sophie
    Cassoux, Nathalie
    Stern, Marc-Henri
    Renault, Shufang
    ANNALS OF SURGERY, 2023, 278 (04) : E827 - E834
  • [29] Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy
    Feng, Min
    Tang, Chengwu
    Feng, Wenming
    Bao, Ying
    Zheng, Yinyuan
    Shen, Jianbin
    ONCOTARGETS AND THERAPY, 2017, 10 : 3001 - 3005
  • [30] Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy
    Narayan, Raja R.
    Datta, Jashodeep
    Goldman, Debra A.
    Aveson, Victoria G.
    Walch, Henry S.
    Sanchez-Vega, Francisco
    Gonen, Mithat
    Balachandran, Vinod P.
    Drebin, Jeffrey A.
    Jarnagin, William R.
    Kingham, T. Peter
    Wei, Alice C.
    Schultz, Nikolaus
    Kemeny, Nancy E.
    D'Angelica, Michael, I
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (12) : 7579 - 7588